Cardio Diagnostics Holdings Stock Market Value
| CDIOW Stock | USD 0.04 0 9.24% |
| Symbol | Cardio |
Cardio Diagnostics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cardio Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardio Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardio Diagnostics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Cardio Diagnostics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Cardio Diagnostics Holdings or generate 0.0% return on investment in Cardio Diagnostics over 30 days. Cardio Diagnostics is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of ca... More
Cardio Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardio Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardio Diagnostics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.65 | |||
| Information Ratio | 0.0277 | |||
| Maximum Drawdown | 76.02 | |||
| Value At Risk | (27.14) | |||
| Potential Upside | 32.01 |
Cardio Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardio Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardio Diagnostics' standard deviation. In reality, there are many statistical measures that can use Cardio Diagnostics historical prices to predict the future Cardio Diagnostics' volatility.| Risk Adjusted Performance | 0.0363 | |||
| Jensen Alpha | 0.2183 | |||
| Total Risk Alpha | (2.15) | |||
| Sortino Ratio | 0.0295 | |||
| Treynor Ratio | 0.1847 |
Cardio Diagnostics Backtested Returns
Cardio Diagnostics is out of control given 3 months investment horizon. Cardio Diagnostics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 19.37% are justified by taking the suggested risk. Use Cardio Diagnostics Risk Adjusted Performance of 0.0363, mean deviation of 11.99, and Downside Deviation of 16.65 to evaluate company specific risk that cannot be diversified away. Cardio Diagnostics holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardio Diagnostics will likely underperform. Use Cardio Diagnostics value at risk, as well as the relationship between the kurtosis and period momentum indicator , to analyze future returns on Cardio Diagnostics.
Auto-correlation | -0.24 |
Weak reverse predictability
Cardio Diagnostics Holdings has weak reverse predictability. Overlapping area represents the amount of predictability between Cardio Diagnostics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardio Diagnostics price movement. The serial correlation of -0.24 indicates that over 24.0% of current Cardio Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cardio Diagnostics lagged returns against current returns
Autocorrelation, which is Cardio Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cardio Diagnostics' stock expected returns. We can calculate the autocorrelation of Cardio Diagnostics returns to help us make a trade decision. For example, suppose you find that Cardio Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cardio Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cardio Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cardio Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cardio Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Cardio Diagnostics Lagged Returns
When evaluating Cardio Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cardio Diagnostics stock have on its future price. Cardio Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cardio Diagnostics autocorrelation shows the relationship between Cardio Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Cardio Diagnostics Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.